[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Transdermal Drug Delivery Systems Consumption Market Report

October 2018 | 166 pages | ID: 29AC1A8942DEN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Transdermal Drug Delivery Systems market for 2018-2023.
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

Over the next five years, LPI(LP Information) projects that Transdermal Drug Delivery Systems will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Drug Delivery Systems market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:
  • Fentanyl
  • Nitroglycerin
  • Estradiol
  • Nicotine
  • Other
Segmentation by application:
  • OTC
  • Rx
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
    • Spain
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
  • Hisamitsu
  • Mylan
  • GSK
  • Novartis
  • Teve(Actavis)
  • Johnson & Johnson
  • UCB
  • Teikoku Seiyaku
  • Bayer
  • Lingrui
  • Sanofi
  • Qizheng
  • Endo
  • Huarun 999
  • Haw Par
  • Nichiban
  • Mentholatum Company
  • Laboratoires Genevrier
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES
  • To study and analyze the global Transdermal Drug Delivery Systems consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Transdermal Drug Delivery Systems market by identifying its various subsegments.
  • Focuses on the key global Transdermal Drug Delivery Systems manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Transdermal Drug Delivery Systems with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the consumption of Transdermal Drug Delivery Systems submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
2018-2023 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Transdermal Drug Delivery Systems Consumption 2013-2023
  2.1.2 Transdermal Drug Delivery Systems Consumption CAGR by Region
2.2 Transdermal Drug Delivery Systems Segment by Type
  2.2.1 Fentanyl
  2.2.2 Nitroglycerin
  2.2.3 Estradiol
  2.2.4 Nicotine
  2.2.5 Other
2.3 Transdermal Drug Delivery Systems Consumption by Type
  2.3.1 Global Transdermal Drug Delivery Systems Consumption Market Share by Type (2013-2018)
  2.3.2 Global Transdermal Drug Delivery Systems Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Transdermal Drug Delivery Systems Sale Price by Type (2013-2018)
2.4 Transdermal Drug Delivery Systems Segment by Application
  2.4.1 OTC
  2.4.2 Rx
2.5 Transdermal Drug Delivery Systems Consumption by Application
  2.5.1 Global Transdermal Drug Delivery Systems Consumption Market Share by Application (2013-2018)
  2.5.2 Global Transdermal Drug Delivery Systems Value and Market Share by Application (2013-2018)
  2.5.3 Global Transdermal Drug Delivery Systems Sale Price by Application (2013-2018)

3 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS BY PLAYERS

3.1 Global Transdermal Drug Delivery Systems Sales Market Share by Players
  3.1.1 Global Transdermal Drug Delivery Systems Sales by Players (2016-2018)
  3.1.2 Global Transdermal Drug Delivery Systems Sales Market Share by Players (2016-2018)
3.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players
  3.2.1 Global Transdermal Drug Delivery Systems Revenue by Players (2016-2018)
  3.2.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2016-2018)
3.3 Global Transdermal Drug Delivery Systems Sale Price by Players
3.4 Global Transdermal Drug Delivery Systems Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Transdermal Drug Delivery Systems Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Transdermal Drug Delivery Systems Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 TRANSDERMAL DRUG DELIVERY SYSTEMS BY REGIONS

4.1 Transdermal Drug Delivery Systems by Regions
  4.1.1 Global Transdermal Drug Delivery Systems Consumption by Regions
  4.1.2 Global Transdermal Drug Delivery Systems Value by Regions
4.2 Americas Transdermal Drug Delivery Systems Consumption Growth
4.3 APAC Transdermal Drug Delivery Systems Consumption Growth
4.4 Europe Transdermal Drug Delivery Systems Consumption Growth
4.5 Middle East & Africa Transdermal Drug Delivery Systems Consumption Growth

5 AMERICAS

5.1 Americas Transdermal Drug Delivery Systems Consumption by Countries
  5.1.1 Americas Transdermal Drug Delivery Systems Consumption by Countries (2013-2018)
  5.1.2 Americas Transdermal Drug Delivery Systems Value by Countries (2013-2018)
5.2 Americas Transdermal Drug Delivery Systems Consumption by Type
5.3 Americas Transdermal Drug Delivery Systems Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Transdermal Drug Delivery Systems Consumption by Countries
  6.1.1 APAC Transdermal Drug Delivery Systems Consumption by Countries (2013-2018)
  6.1.2 APAC Transdermal Drug Delivery Systems Value by Countries (2013-2018)
6.2 APAC Transdermal Drug Delivery Systems Consumption by Type
6.3 APAC Transdermal Drug Delivery Systems Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Transdermal Drug Delivery Systems by Countries
  7.1.1 Europe Transdermal Drug Delivery Systems Consumption by Countries (2013-2018)
  7.1.2 Europe Transdermal Drug Delivery Systems Value by Countries (2013-2018)
7.2 Europe Transdermal Drug Delivery Systems Consumption by Type
7.3 Europe Transdermal Drug Delivery Systems Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Transdermal Drug Delivery Systems by Countries
  8.1.1 Middle East & Africa Transdermal Drug Delivery Systems Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Transdermal Drug Delivery Systems Value by Countries (2013-2018)
8.2 Middle East & Africa Transdermal Drug Delivery Systems Consumption by Type
8.3 Middle East & Africa Transdermal Drug Delivery Systems Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Transdermal Drug Delivery Systems Distributors
10.3 Transdermal Drug Delivery Systems Customer

11 GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET FORECAST

11.1 Global Transdermal Drug Delivery Systems Consumption Forecast (2018-2023)
11.2 Global Transdermal Drug Delivery Systems Forecast by Regions
  11.2.1 Global Transdermal Drug Delivery Systems Forecast by Regions (2018-2023)
  11.2.2 Global Transdermal Drug Delivery Systems Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Transdermal Drug Delivery Systems Forecast by Type
11.8 Global Transdermal Drug Delivery Systems Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Hisamitsu
  12.1.1 Company Details
  12.1.2 Transdermal Drug Delivery Systems Product Offered
  12.1.3 Hisamitsu Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Hisamitsu News
12.2 Mylan
  12.2.1 Company Details
  12.2.2 Transdermal Drug Delivery Systems Product Offered
  12.2.3 Mylan Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 Mylan News
12.3 GSK
  12.3.1 Company Details
  12.3.2 Transdermal Drug Delivery Systems Product Offered
  12.3.3 GSK Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 GSK News
12.4 Novartis
  12.4.1 Company Details
  12.4.2 Transdermal Drug Delivery Systems Product Offered
  12.4.3 Novartis Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Novartis News
12.5 Teve(Actavis)
  12.5.1 Company Details
  12.5.2 Transdermal Drug Delivery Systems Product Offered
  12.5.3 Teve(Actavis) Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 Teve(Actavis) News
12.6 Johnson & Johnson
  12.6.1 Company Details
  12.6.2 Transdermal Drug Delivery Systems Product Offered
  12.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 Johnson & Johnson News
12.7 UCB
  12.7.1 Company Details
  12.7.2 Transdermal Drug Delivery Systems Product Offered
  12.7.3 UCB Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 UCB News
12.8 Teikoku Seiyaku
  12.8.1 Company Details
  12.8.2 Transdermal Drug Delivery Systems Product Offered
  12.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Teikoku Seiyaku News
12.9 Bayer
  12.9.1 Company Details
  12.9.2 Transdermal Drug Delivery Systems Product Offered
  12.9.3 Bayer Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Bayer News
12.10 Lingrui
  12.10.1 Company Details
  12.10.2 Transdermal Drug Delivery Systems Product Offered
  12.10.3 Lingrui Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Lingrui News
12.11 Sanofi
12.12 Qizheng
12.13 Endo
12.14 Huarun
12.15 Haw Par
12.16 Nichiban
12.17 Mentholatum Company
12.18 Laboratoires Genevrier

13 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES AND FIGURES

Figure Picture of Transdermal Drug Delivery Systems
Table Product Specifications of Transdermal Drug Delivery Systems
Figure Transdermal Drug Delivery Systems Report Years Considered
Figure Market Research Methodology
Figure Global Transdermal Drug Delivery Systems Consumption Growth Rate 2013-2023 (M Units)
Figure Global Transdermal Drug Delivery Systems Value Growth Rate 2013-2023 ($ Millions)
Table Transdermal Drug Delivery Systems Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Fentanyl
Table Major Players of Fentanyl
Figure Product Picture of Nitroglycerin
Table Major Players of Nitroglycerin
Figure Product Picture of Estradiol
Table Major Players of Estradiol
Figure Product Picture of Nicotine
Table Major Players of Nicotine
Figure Product Picture of Other
Table Major Players of Other
Table Global Consumption Sales by Type (2013-2018)
Table Global Transdermal Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure Global Transdermal Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Table Global Transdermal Drug Delivery Systems Revenue by Type (2013-2018) ($ million)
Table Global Transdermal Drug Delivery Systems Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Transdermal Drug Delivery Systems Value Market Share by Type (2013-2018)
Table Global Transdermal Drug Delivery Systems Sale Price by Type (2013-2018)
Figure Transdermal Drug Delivery Systems Consumed in OTC
Figure Global Transdermal Drug Delivery Systems Market: OTC (2013-2018) (M Units)
Figure Global Transdermal Drug Delivery Systems Market: OTC (2013-2018) ($ Millions)
Figure Global OTC YoY Growth ($ Millions)
Figure Transdermal Drug Delivery Systems Consumed in Rx
Figure Global Transdermal Drug Delivery Systems Market: Rx (2013-2018) (M Units)
Figure Global Transdermal Drug Delivery Systems Market: Rx (2013-2018) ($ Millions)
Figure Global Rx YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Transdermal Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure Global Transdermal Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Table Global Transdermal Drug Delivery Systems Value by Application (2013-2018)
Table Global Transdermal Drug Delivery Systems Value Market Share by Application (2013-2018)
Figure Global Transdermal Drug Delivery Systems Value Market Share by Application (2013-2018)
Table Global Transdermal Drug Delivery Systems Sale Price by Application (2013-2018)
Table Global Transdermal Drug Delivery Systems Sales by Players (2016-2018) (M Units)
Table Global Transdermal Drug Delivery Systems Sales Market Share by Players (2016-2018)
Figure Global Transdermal Drug Delivery Systems Sales Market Share by Players in 2016
Figure Global Transdermal Drug Delivery Systems Sales Market Share by Players in 2017
Table Global Transdermal Drug Delivery Systems Revenue by Players (2016-2018) ($ Millions)
Table Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2016-2018)
Figure Global Transdermal Drug Delivery Systems Revenue Market Share by Players in 2016
Figure Global Transdermal Drug Delivery Systems Revenue Market Share by Players in 2017
Table Global Transdermal Drug Delivery Systems Sale Price by Players (2016-2018)
Figure Global Transdermal Drug Delivery Systems Sale Price by Players in 2017
Table Global Transdermal Drug Delivery Systems Manufacturing Base Distribution and Sales Area by Players
Table Players Transdermal Drug Delivery Systems Products Offered
Table Transdermal Drug Delivery Systems Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Transdermal Drug Delivery Systems Consumption by Regions 2013-2018 (M Units)
Table Global Transdermal Drug Delivery Systems Consumption Market Share by Regions 2013-2018
Figure Global Transdermal Drug Delivery Systems Consumption Market Share by Regions 2013-2018
Table Global Transdermal Drug Delivery Systems Value by Regions 2013-2018 ($ Millions)
Table Global Transdermal Drug Delivery Systems Value Market Share by Regions 2013-2018
Figure Global Transdermal Drug Delivery Systems Value Market Share by Regions 2013-2018
Figure Americas Transdermal Drug Delivery Systems Consumption 2013-2018 (M Units)
Figure Americas Transdermal Drug Delivery Systems Value 2013-2018 ($ Millions)
Figure APAC Transdermal Drug Delivery Systems Consumption 2013-2018 (M Units)
Figure APAC Transdermal Drug Delivery Systems Value 2013-2018 ($ Millions)
Figure Europe Transdermal Drug Delivery Systems Consumption 2013-2018 (M Units)
Figure Europe Transdermal Drug Delivery Systems Value 2013-2018 ($ Millions)
Figure Middle East & Africa Transdermal Drug Delivery Systems Consumption 2013-2018 (M Units)
Figure Middle East & Africa Transdermal Drug Delivery Systems Value 2013-2018 ($ Millions)
Table Americas Transdermal Drug Delivery Systems Consumption by Countries (2013-2018) (M Units)
Table Americas Transdermal Drug Delivery Systems Consumption Market Share by Countries (2013-2018)
Figure Americas Transdermal Drug Delivery Systems Consumption Market Share by Countries in 2017
Table Americas Transdermal Drug Delivery Systems Value by Countries (2013-2018) ($ Millions)
Table Americas Transdermal Drug Delivery Systems Value Market Share by Countries (2013-2018)
Figure Americas Transdermal Drug Delivery Systems Value Market Share by Countries in 2017
Table Americas Transdermal Drug Delivery Systems Consumption by Type (2013-2018) (M Units)
Table Americas Transdermal Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure Americas Transdermal Drug Delivery Systems Consumption Market Share by Type in 2017
Table Americas Transdermal Drug Delivery Systems Consumption by Application (2013-2018) (M Units)
Table Americas Transdermal Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure Americas Transdermal Drug Delivery Systems Consumption Market Share by Application in 2017
Figure United States Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure United States Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Canada Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Canada Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Mexico Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Mexico Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Table APAC Transdermal Drug Delivery Systems Consumption by Countries (2013-2018) (M Units)
Table APAC Transdermal Drug Delivery Systems Consumption Market Share by Countries (2013-2018)
Figure APAC Transdermal Drug Delivery Systems Consumption Market Share by Countries in 2017
Table APAC Transdermal Drug Delivery Systems Value by Countries (2013-2018) ($ Millions)
Table APAC Transdermal Drug Delivery Systems Value Market Share by Countries (2013-2018)
Figure APAC Transdermal Drug Delivery Systems Value Market Share by Countries in 2017
Table APAC Transdermal Drug Delivery Systems Consumption by Type (2013-2018) (M Units)
Table APAC Transdermal Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure APAC Transdermal Drug Delivery Systems Consumption Market Share by Type in 2017
Table APAC Transdermal Drug Delivery Systems Consumption by Application (2013-2018) (M Units)
Table APAC Transdermal Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure APAC Transdermal Drug Delivery Systems Consumption Market Share by Application in 2017
Figure China Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure China Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Japan Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Japan Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Korea Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Korea Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Southeast Asia Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure India Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure India Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Australia Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Australia Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Table Europe Transdermal Drug Delivery Systems Consumption by Countries (2013-2018) (M Units)
Table Europe Transdermal Drug Delivery Systems Consumption Market Share by Countries (2013-2018)
Figure Europe Transdermal Drug Delivery Systems Consumption Market Share by Countries in 2017
Table Europe Transdermal Drug Delivery Systems Value by Countries (2013-2018) ($ Millions)
Table Europe Transdermal Drug Delivery Systems Value Market Share by Countries (2013-2018)
Figure Europe Transdermal Drug Delivery Systems Value Market Share by Countries in 2017
Table Europe Transdermal Drug Delivery Systems Consumption by Type (2013-2018) (M Units)
Table Europe Transdermal Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure Europe Transdermal Drug Delivery Systems Consumption Market Share by Type in 2017
Table Europe Transdermal Drug Delivery Systems Consumption by Application (2013-2018) (M Units)
Table Europe Transdermal Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure Europe Transdermal Drug Delivery Systems Consumption Market Share by Application in 2017
Figure Germany Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Germany Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure France Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure France Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure UK Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure UK Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Italy Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Italy Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Russia Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Russia Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Spain Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Spain Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Transdermal Drug Delivery Systems Consumption by Countries (2013-2018) (M Units)
Table Middle East & Africa Transdermal Drug Delivery Systems Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Transdermal Drug Delivery Systems Consumption Market Share by Countries in 2017
Table Middle East & Africa Transdermal Drug Delivery Systems Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Transdermal Drug Delivery Systems Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Transdermal Drug Delivery Systems Value Market Share by Countries in 2017
Table Middle East & Africa Transdermal Drug Delivery Systems Consumption by Type (2013-2018) (M Units)
Table Middle East & Africa Transdermal Drug Delivery Systems Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Transdermal Drug Delivery Systems Consumption Market Share by Type in 2017
Table Middle East & Africa Transdermal Drug Delivery Systems Consumption by Application (2013-2018) (M Units)
Table Middle East & Africa Transdermal Drug Delivery Systems Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Transdermal Drug Delivery Systems Consumption Market Share by Application in 2017
Figure Egypt Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Egypt Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure South Africa Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure South Africa Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Israel Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Israel Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure Turkey Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure Turkey Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Transdermal Drug Delivery Systems Consumption Growth 2013-2018 (M Units)
Figure GCC Countries Transdermal Drug Delivery Systems Value Growth 2013-2018 ($ Millions)
Table Transdermal Drug Delivery Systems Distributors List
Table Transdermal Drug Delivery Systems Customer List
Figure Global Transdermal Drug Delivery Systems Consumption Growth Rate Forecast (2018-2023) (M Units)
Figure Global Transdermal Drug Delivery Systems Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Transdermal Drug Delivery Systems Consumption Forecast by Countries (2018-2023) (M Units)
Table Global Transdermal Drug Delivery Systems Consumption Market Forecast by Regions
Table Global Transdermal Drug Delivery Systems Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Transdermal Drug Delivery Systems Value Market Share Forecast by Regions
Figure Americas Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Americas Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure APAC Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure APAC Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Europe Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Europe Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Middle East & Africa Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Middle East & Africa Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure United States Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure United States Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Canada Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Canada Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Mexico Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Mexico Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Brazil Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Brazil Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure China Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure China Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Japan Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Japan Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Korea Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Korea Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Southeast Asia Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Southeast Asia Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure India Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure India Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Australia Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Australia Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Germany Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Germany Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure France Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure France Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure UK Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure UK Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Italy Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Italy Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Russia Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Russia Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Spain Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Spain Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Egypt Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Egypt Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure South Africa Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure South Africa Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Israel Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Israel Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure Turkey Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure Turkey Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Figure GCC Countries Transdermal Drug Delivery Systems Consumption 2018-2023 (M Units)
Figure GCC Countries Transdermal Drug Delivery Systems Value 2018-2023 ($ Millions)
Table Global Transdermal Drug Delivery Systems Consumption Forecast by Type (2018-2023) (M Units)
Table Global Transdermal Drug Delivery Systems Consumption Market Share Forecast by Type (2018-2023)
Table Global Transdermal Drug Delivery Systems Value Forecast by Type (2018-2023) ($ Millions)
Table Global Transdermal Drug Delivery Systems Value Market Share Forecast by Type (2018-2023)
Table Global Transdermal Drug Delivery Systems Consumption Forecast by Application (2018-2023) (M Units)
Table Global Transdermal Drug Delivery Systems Consumption Market Share Forecast by Application (2018-2023)
Table Global Transdermal Drug Delivery Systems Value Forecast by Application (2018-2023) ($ Millions)
Table Global Transdermal Drug Delivery Systems Value Market Share Forecast by Application (2018-2023)
Table Hisamitsu Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hisamitsu Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hisamitsu Transdermal Drug Delivery Systems Market Share (2016-2018)
Table Mylan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mylan Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Mylan Transdermal Drug Delivery Systems Market Share (2016-2018)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GSK Transdermal Drug Delivery Systems Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Transdermal Drug Delivery Systems Market Share (2016-2018)
Table Teve(Actavis) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teve(Actavis) Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teve(Actavis) Transdermal Drug Delivery Systems Market Share (2016-2018)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Johnson & Johnson Transdermal Drug Delivery Systems Market Share (2016-2018)
Table UCB Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure UCB Transdermal Drug Delivery Systems Market Share (2016-2018)
Table Teikoku Seiyaku Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teikoku Seiyaku Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teikoku Seiyaku Transdermal Drug Delivery Systems Market Share (2016-2018)
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bayer Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Bayer Transdermal Drug Delivery Systems Market Share (2016-2018)
Table Lingrui Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Lingrui Transdermal Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Lingrui Transdermal Drug Delivery Systems Market Share (2016-2018)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Qizheng Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Endo Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Huarun 999 Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Haw Par Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Nichiban Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Mentholatum Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Laboratoires Genevrier Basic Information, Manufacturing Base, Sales Area and Its Competitors


More Publications